Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study
| dc.contributor.author | Katz, Ingrid T | |
| dc.contributor.author | Kaplan, Richard | |
| dc.contributor.author | Fitzmaurice, Garrett | |
| dc.contributor.author | Leone, Dominick | |
| dc.contributor.author | Bangsberg, David R | |
| dc.contributor.author | Bekker, Linda‐Gail | |
| dc.contributor.author | Orrell, Catherine | |
| dc.date.accessioned | 2021-10-08T07:15:52Z | |
| dc.date.available | 2021-10-08T07:15:52Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibility from an initial CD4+ threshold of ≤200 cells/μl to providing ART for all people living with HIV (PLWH) as of September 2016. We evaluated the association of programmatic changes in ART eligibility with loss from care, both prior to ART initiation and within the first 16 weeks of starting treatment, during a period of programmatic expansion to ART treatment at CD4+ ≤ 350 cells/μl. | |
| dc.identifier.apacitation | Katz, I. T., Kaplan, R., Fitzmaurice, G., Leone, D., Bangsberg, D. R., , & Orrell, C. (2017). Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study. <i>PLoS Medicine</i>, 14(11), e1002434 - 177. http://hdl.handle.net/11427/34714 | en_ZA |
| dc.identifier.chicagocitation | Katz, Ingrid T, Richard Kaplan, Garrett Fitzmaurice, Dominick Leone, David R Bangsberg, , and Catherine Orrell "Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study." <i>PLoS Medicine</i> 14, 11. (2017): e1002434 - 177. http://hdl.handle.net/11427/34714 | en_ZA |
| dc.identifier.citation | Katz, I.T., Kaplan, R., Fitzmaurice, G., Leone, D., Bangsberg, D.R., & Orrell, C. 2017. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study. <i>PLoS Medicine.</i> 14(11):e1002434 - 177. http://hdl.handle.net/11427/34714 | en_ZA |
| dc.identifier.issn | 1549-1277 | |
| dc.identifier.issn | 1549-1676 | |
| dc.identifier.ris | TY - Journal Article AU - Katz, Ingrid T AU - Kaplan, Richard AU - Fitzmaurice, Garrett AU - Leone, Dominick AU - Bangsberg, David R AU - Bekker, Linda‐Gail AU - Orrell, Catherine AB - South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibility from an initial CD4+ threshold of ≤200 cells/μl to providing ART for all people living with HIV (PLWH) as of September 2016. We evaluated the association of programmatic changes in ART eligibility with loss from care, both prior to ART initiation and within the first 16 weeks of starting treatment, during a period of programmatic expansion to ART treatment at CD4+ ≤ 350 cells/μl. DA - 2017 DB - OpenUCT DP - University of Cape Town IS - 11 J1 - PLoS Medicine LK - https://open.uct.ac.za PY - 2017 SM - 1549-1277 SM - 1549-1676 T1 - Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study TI - Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study UR - http://hdl.handle.net/11427/34714 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/34714 | |
| dc.identifier.vancouvercitation | Katz IT, Kaplan R, Fitzmaurice G, Leone D, Bangsberg DR, , et al. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study. PLoS Medicine. 2017;14(11):e1002434 - 177. http://hdl.handle.net/11427/34714. | en_ZA |
| dc.language.iso | eng | |
| dc.publisher.department | Desmond Tutu HIV Centre | |
| dc.publisher.faculty | Faculty of Health Sciences | |
| dc.source | PLoS Medicine | |
| dc.source.journalissue | 11 | |
| dc.source.journalvolume | 14 | |
| dc.source.pagination | e1002434 - 177 | |
| dc.source.uri | https://dx.doi.org/10.1371/journal.pmed.1002434 | |
| dc.subject.other | Biology and Life Sciences | |
| dc.subject.other | Immunology | |
| dc.subject.other | Vaccination and Immunization | |
| dc.subject.other | Antiviral Therapy | |
| dc.subject.other | Antiretroviral Therapy | |
| dc.subject.other | Medicine and Health Sciences | |
| dc.subject.other | Public and Occupational Health | |
| dc.subject.other | Preventive Medicine | |
| dc.subject.other | Microbiology | |
| dc.subject.other | Medical Microbiology | |
| dc.subject.other | Microbial Pathogens | |
| dc.subject.other | Viral Pathogens | |
| dc.subject.other | Immunodeficiency Viruses | |
| dc.subject.other | HIV | |
| dc.subject.other | Pathology and Laboratory Medicine | |
| dc.subject.other | Pathogens | |
| dc.subject.other | Organisms | |
| dc.subject.other | Viruses | |
| dc.subject.other | Biology and life sciences | |
| dc.subject.other | RNA viruses | |
| dc.subject.other | Retroviruses | |
| dc.subject.other | Lentivirus | |
| dc.subject.other | Health Care | |
| dc.subject.other | Health Care Policy | |
| dc.title | Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study | |
| dc.type | Journal Article | |
| uct.type.publication | Research | |
| uct.type.resource | Journal Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- KatzIngridT_Treatment_guide_2017.pdf
- Size:
- 1.4 MB
- Format:
- Adobe Portable Document Format
- Description: